- Comparison of Efficacy of Peginterferon and Ribavirin Combination Therapy for Chronic Hepatitis C among Korean, Caucasian and Other Asians
-
Kim KA
- KMID: 1775791
- Korean J Gastroenterol.
- 2012 Nov;60(5):273-274.
- doi: 10.4166/kjg.2012.60.5.273
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
-
Rou WS, Lee BS
- KMID: 2164361
- Clin Mol Hepatol.
- 2015 Jun;21(2):122-124.
- doi: 10.3350/cmh.2015.21.2.122
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
-
Jung YK, Kim JH
- KMID: 1493571
- Clin Mol Hepatol.
- 2013 Mar;19(1):26-28.
- doi: 10.3350/cmh.2013.19.1.26
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
-
Chung WJ
- KMID: 1392905
- Clin Mol Hepatol.
- 2012 Sep;18(3):268-271.
- doi: 10.3350/cmh.2012.18.3.268
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
-
Heo J
- KMID: 1025196
- Korean J Hepatol.
- 2011 Sep;17(3):180-182.
- doi: 10.3350/kjhep.2011.17.3.180
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection
-
Kim TY
- KMID: 1372648
- Korean J Hepatol.
- 2012 Mar;18(1):29-31.
- doi: 10.3350/kjhep.2012.18.1.29
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized Controlled Trial of Sodium Phosphate Tablets versus 2 L Polyethylene Glycol Solution for Bowel Cleansing prior to Colonoscopy
-
Lee YH, Jeong SY, Kim YS, Jung HJ, Kwon MJ, Kwak CH, Bae SI, Moon JS, Kim JW, Kim SH, Lee KL
- KMID: 2373177
- Korean J Gastroenterol.
- 2015 Jan;65(1):27-34.
- doi: 10.4166/kjg.2015.65.1.27
BACKGROUND/AIMS: Performance of polyethylene glycol solution (PEG) is often unsatisfactory as bowel preparation agent for colonoscopy. In order to provide equivalent efficacy with better patient tolerance, sodium phosphate tablet (SPT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC
- KMID: 2373140
- Clin Mol Hepatol.
- 2016 Sep;22(3):390-395.
- doi: 10.3350/cmh.2015.0050
Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression... -
- CITED
-
- Close
- SHARE
-
- Close
- Goals of Treatment, Indication, and Treatment for Chronic Hepatits C
-
Paik SW
- KMID: 1767541
- Korean J Gastroenterol.
- 2008 Jun;51(6):368-371.
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatic fibrosis worldwide. Up to 85% of individuals infected with HCV develop chronic infection, which can progress to... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
-
Wi CI, Kim WR, Gross JB, Stadheim L, Poterucha
- KMID: 2412051
- Gut Liver.
- 2016 Jul;10(4):611-616.
- doi: 10.5009/gnl14256
BACKGROUND/AIMS: Despite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
-
Park SY, Rim MY, Yo IK, Ha MS, Kim JS, Lee JW, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1775796
- Korean J Gastroenterol.
- 2012 Nov;60(5):306-314.
- doi: 10.4166/kjg.2012.60.5.306
BACKGROUND/AIMS: A combination of peginterferon and ribavirin is the standard therapy for chronic hepatitis C (CHC). However, the respective study has not been carried out in a large scale in... -
- CITED
-
- Close
- SHARE
-
- Close
- Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon alpha Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
-
Ali FT, Ali MA, Elgizawy M, Elsawy AM
- KMID: 2160636
- Gut Liver.
- 2015 Jul;9(4):516-524.
- doi: 10.5009/gnl14162
BACKGROUND/AIMS: The T-helper 1 (TH1) immune reaction is essential for the eradication of hepatitis C virus (HCV) during pegylated interferon alpha (PEG-IFN-alpha)- and ribavirin (RBV)-based therapy in chronic HCV patients.... -
- CITED
-
- Close
- SHARE
-
- Close
- Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
-
Oh J, Joo KW, Chin HJ, Chae DW, Kim SG, Kim SJ, Chung W, Kim S, Huh W, Oh HY, Choi BS, Yang CW, Kim S
- KMID: 1796918
- J Korean Med Sci.
- 2014 Jan;29(1):76-83.
- doi: 10.3346/jkms.2014.29.1.76
Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half life. This study investigated the efficacy of CERA for correcting anemia in Korean patients on dialysis. Patients (> or... -
- CITED
-
- Close
- SHARE
-
- Close
- High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
-
Heo NY, Lim YS, Lee HC, Lee YS, Kim KM, Byun KS, Han KH, Lee KS, Paik SW, Yoon SK, Suh DJ
- KMID: 1493576
- Clin Mol Hepatol.
- 2013 Mar;19(1):60-69.
- doi: 10.3350/cmh.2013.19.1.60
BACKGROUND/AIMS: Identifying the impact of a patient's ethnicity on treatment responses in clinical practice may assist in providing individualized treatment regimens for chronic hepatitis C (CHC). The effectiveness of standard... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pegylated Interferon Alpha-2a Monotherapy in a Peritoneal Dialysis Patient with Chronic Hepatitis C
-
Tae HJ, Jun DW, Choi JW, Kim WJ, Kim BY, Sohn JH, Lee MH
- KMID: 1718419
- Korean J Gastroenterol.
- 2011 Aug;58(2):107-110.
- doi: 10.4166/kjg.2011.58.2.107
Pegylated interferon (PEG-IFN) is now the standard treatment for chronic hepatitis C. But, there are few reports about patients with end stage renal disease, and treatment protocol for HCV infection... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection
-
Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
- KMID: 1073303
- Korean J Hepatol.
- 2008 Dec;14(4):513-518.
- doi: 10.3350/kjhep.2008.14.4.513
The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
-
Jeong SW, Kim JD, Woo HY, You CR, Lee SW, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 1374962
- Korean J Hepatol.
- 2009 Sep;15(3):338-349.
- doi: 10.3350/kjhep.2009.15.3.338
BACKGROUND/AIMS: Various predictive factors for peginterferon alpha and ribavirin therapy in chronic hepatitis C have been reported, but the effect of adherence to therapy has not been established. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of Sustained Virologic Response in Chronic Hepatitis C: Analysis of Factors Related to Relapse after Sustained Virologic Response with Peginterferon Plus Ribavirin Combination Therapy
-
Lee JE, Yoon NR, Kim JD, Song MJ, Kwon JH, Bae SH, Choi JY, Jeong SW, Yoon SK
- KMID: 1128356
- Korean J Gastroenterol.
- 2011 Mar;57(3):173-179.
- doi: 10.4166/kjg.2011.57.3.173
BACKGROUND/AIMS: Pegylated interferon plus ribavirin combination therapy has been the standard of therapy for patients with chronic hepatitis C. Although previous studies have reported long term durability after the sustained... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
-
Choi SB, Lee YJ, Lee JI, Song YJ, Choi BJ, Kim JH, Jung EU, Park SJ, Lee SH, Kim JH, Choi JS, Jee SR, Seol SY
- KMID: 1025197
- Korean J Hepatol.
- 2011 Sep;17(3):183-188.
- doi: 10.3350/kjhep.2011.17.3.183
BACKGROUND/AIMS: The reappearance rates of hepatitis C virus (HCV) RNA after a sustained virological response (SVR) have been reported to be 1-2%. We investigated the reappearance rate of HCV RNA... -
- CITED
-
- Close
- SHARE
-
- Close
- Importance of Medication Adherence to Peginterferon-Ribavirin Combination Therapy in Patients with Chronic Hepatitis C
-
Goh PG, Kim MJ, Kim HJ, Eun HS, Kim ES, Kim YJ, Lee SY, Moon HS, Lee ES, Kim SH, Lee BS, Lee HY
- KMID: 1792786
- Korean J Gastroenterol.
- 2011 May;57(5):294-301.
- doi: 10.4166/kjg.2011.57.5.294
BACKGROUND/AIMS: The combination therapy with peginterferon and ribavirin is a standard treatment for patients with chronic hepatitis C. However, because of the long duration of the treatment and many complications,... -
- CITED
-
- Close
- SHARE
-
- Close
